Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Colistimethate sodium

EU orphan designation number: EU/3/02/088
Active ingredient: Colistimethate sodium
Indication: Treatment of Pseudomonas aeruginosa lung infection (including colonisation) in cystic fibrosis
Sponsor: Forest Laboratories UK Ltd
Riverbridge House, Anchor Boulevard, Crossways Business Park, Dartford, Kent DA2 6SL, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2002 Centralised Orphan - Designation EMEA/OD/057/01 (2002)648 of 19/02/2002
15/10/2009 Other procedure EMEA/OD/057/01